CompletedNCT00869479

Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis

Studying Nephrogenic systemic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Jonathan Kay, MD
Massachusetts General Hospital
Enrollment
60 enrolled
Eligibility
18 years · All sexes
Timeline
20092010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00869479 on ClinicalTrials.gov
← Back to all trials